Status:
COMPLETED
Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
Charles Y. C. Pak Foundation
Conditions:
Prostate Cancer
Eligibility:
MALE
55-89 years
Brief Summary
The overall goal of this pilot project is to test the hypothesis that a decline in muscle strength precedes the decline in bone strength in men undergoing androgen deprivation therapy (ADT) for prosta...
Detailed Description
Twenty-five men from urology clinic with prostate cancer will be recruited and enrolled prior to initiating ADT and studied at three time points. Baseline (before first does of ADT), and at approximat...
Eligibility Criteria
Inclusion
- • Dx with prostate cancer and planned ADT therapy
Exclusion
- Contraindication to MRI
- Limited life expectancy
- Inability to participate in exercise testing
- Severe functional impairment
- Chronic kidney disease 4 or worse
- Hgb \< 9
- Use of anti-resorptive agent
- non-English speaking
- Bone metastasis
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 29 2020
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03386812
Start Date
October 1 2017
End Date
November 29 2020
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern
Dallas, Texas, United States, 75390-8889